transplant
syngen
neural
progenitor
cell
npc
mice
persist
infect
jhm
strain
mous
hepat
viru
jhmv
result
enhanc
differenti
oligodendrocyt
progenitor
cell
opc
associ
remyelin
axon
spare
clinic
improv
whether
allogen
npc
toler
induc
immunemedi
reject
controversi
poorli
defin
neuroinflammatori
demyelin
condit
use
jhmvinduc
demyelin
model
evalu
antigen
transplant
allogen
npc
within
central
nervou
system
cn
mice
establish
immunemedi
demyelin
cultur
npc
constitut
express
costimulatori
molecul
treatment
induc
express
mhc
class
ii
antigen
inject
allogen
npc
b
background
led
delay
type
hypersensit
dth
respons
balbc
background
associ
cell
prolifer
secret
follow
cocultur
allogen
npc
transplant
mhcmismatch
npc
jhmvinfect
mice
result
increas
transcript
encod
cell
chemoattract
chemokin
correl
increas
cell
infiltr
associ
npc
reject
treatment
mhcmismatch
mice
cell
subsetspecif
deplet
antibodi
increas
surviv
allogen
npc
without
affect
commit
oligodendroyt
lineag
collect
result
show
allogen
npc
antigen
cell
contribut
reject
follow
transplant
inflam
cn
suggest
immunomodulatori
treatment
may
necessari
prolong
surviv
allogen
cell
multipl
sclerosi
ms
common
caus
neurolog
disabl
young
adult
etiolog
ms
thought
multifactori
includ
genet
environment
factor
may
lead
initi
mainten
andor
progress
diseas
exampl
viral
infect
long
consid
potenti
trigger
mechan
involv
demyelin
numer
human
viral
pathogen
suggest
involv
elicit
myelinreact
lymphocyt
andor
antibodi
subsequ
infiltr
central
nervou
system
cn
damag
myelin
sheath
therefor
viral
model
demyelin
clearli
relev
provid
import
insight
mechan
associ
diseas
initi
neuroinflamm
demyelin
remyelin
import
clinic
aspect
relat
pathogenesi
ms
eventu
remyelin
failur
chronic
demyelin
plaqu
endogen
oligodendrocyt
progenitor
cell
opc
mind
cellbas
therapi
use
neural
progenitor
cell
npc
emerg
potenti
viabl
approach
promot
remyelin
laboratori
recent
demonstr
transplant
syngen
mous
npc
mice
persist
infect
neurotrop
jhm
strain
mous
hepat
viru
jhmv
well
toler
associ
axon
spare
accompani
extens
remyelin
significantli
dampen
either
neuroinflamm
cell
respons
evid
work
abil
engraft
npc
migrat
colon
region
demyelin
respond
chemokin
ligand
ii
preferenti
differenti
cell
oligodendrocyt
linag
iii
promot
axon
spare
remyelin
npc
transplant
offer
promis
therapeut
approach
promot
remyelin
patient
demyelin
diseas
ms
howev
similar
solidorgan
transplant
donor
specif
allogen
respons
like
occur
may
requir
lifelong
immunosuppress
elev
suscept
opportunist
infect
tumor
therefor
import
clinic
relev
question
relat
stem
cell
therapi
revolv
around
allograft
reject
implant
allogen
stem
cell
may
selfderiv
particularli
import
consid
cellular
transplant
treatment
chronic
neurodegen
diseas
ongo
debat
center
whether
mhc
match
critic
success
engraft
cn
compel
evid
argu
unmatch
graft
welltoler
within
cn
due
mute
immunogen
npc
clinic
studi
support
transplant
allogen
npc
result
prolong
surviv
howev
immunoprivileg
statu
npc
recent
question
recent
studi
argu
mhc
mismatch
diminish
surviv
npc
mute
endogen
neurogenesi
associ
innat
immun
respons
moreov
transplant
allogen
npc
model
spinal
cord
injuri
result
activ
immun
system
npc
reject
find
indic
order
longterm
engraft
npc
efficaci
use
immunomodulatori
agent
must
consid
mind
imper
determin
allogen
npc
antigen
follow
transplant
environ
establish
inflammatori
demyelin
diseas
end
provid
evid
allogen
npc
recogn
foreign
infiltr
lymphocyt
contribut
reject
follow
transplant
jhmvinfect
mice
establish
demyelin
agematch
b
nation
cancer
institut
nci
frederick
md
balbc
nci
mice
infect
intracrani
ic
balbc
plaqu
form
unit
pfu
mhv
strain
jhmv
steril
hbss
transplant
studi
intraperiton
ip
pfu
dm
strain
jhmv
suspend
steril
hbss
cell
condit
media
cm
prepar
mice
sacrif
variou
day
post
infect
pi
spinal
cord
remov
process
analysi
experi
approv
univers
california
irvin
institut
anim
care
use
committe
enhanc
green
fluoresc
protein
express
npc
gfpnpc
deriv
mice
cultur
previous
describ
undifferenti
gfpnpc
transplant
hbssmous
spinal
cord
day
postinfect
pi
syngen
balbc
allogen
mice
previous
publish
time
point
transplant
chosen
sinc
viru
inflamm
wane
demyelin
peak
sham
control
virallyinfect
mice
transplant
hbss
alon
recombin
mous
purchas
cell
scienc
canton
mlr
vitro
method
assay
cell
prolifer
respons
alloantigen
cell
isol
pool
spleen
harvest
naiv
infect
mice
day
pt
respond
cell
popul
purifi
neg
select
use
pan
cell
isol
kit
miltenyi
biotec
auburn
ca
ms
column
compos
ferromagnet
sphere
capabl
separ
magnet
label
unlabel
cell
place
column
attach
magnet
miltenyi
biotec
load
column
wash
hbss
remov
collect
unlabel
cell
cell
separ
popul
stain
peconjug
bd
bioscienc
clone
ebiosci
clone
antibodi
sort
facsaria
bd
bioscienc
franklin
lake
nj
aliquot
enrich
cell
stain
min
room
temperatur
label
dye
ebiosci
excit
detect
apc
filter
cell
divid
dye
express
dampen
evenli
distribut
daughter
cell
stain
cell
immedi
wash
pb
fetal
calf
serum
stimul
popul
cell
includ
control
splenocyt
npc
treat
mitomycin
c
ag
scientif
san
diego
ca
min
cell
wash
hbss
stimul
respond
plate
togeth
round
bottom
plate
presenc
absenc
recombin
mous
cocultur
cell
incub
day
number
divid
respond
cell
isol
spleen
balbc
mice
day
pt
compar
number
divid
respond
cell
isol
spleen
naiv
balbc
mice
statist
signific
elispot
assay
captur
secret
protein
specif
antibodyco
micropl
use
determin
memori
cell
activ
detect
secret
frequenc
alloreact
cell
assess
perform
h
mlr
purifi
cell
well
multiscreenip
plate
millipor
billerica
respond
cell
purifi
spleen
naiv
balbc
mice
balbc
mice
day
pt
mac
sort
describ
stimul
cell
popul
splenocyt
gfpnpc
stimul
respond
incub
previous
describ
minimum
well
per
experiment
condit
briefli
plate
coat
captur
antibodi
ebiosci
clone
prior
mlr
plate
wash
tween
follow
h
incub
c
biotinyl
detect
antibodi
ebiosci
clone
plate
wash
pb
tween
incub
streptavidin
ap
invitrogen
carlsbad
ca
minut
room
temperatur
plate
wash
pb
incub
per
well
bcipnbt
sigma
st
loui
mo
spot
develop
spot
count
use
dissect
microscop
repeat
measur
anova
perform
statist
analysi
dth
assay
employ
determin
memori
cell
present
antigensensit
anim
balbc
mice
sensit
subcutan
flank
inject
splenocyt
cell
gfpnpc
cell
day
later
challeng
footpad
inject
either
splenocyt
npc
footpad
swell
measur
defin
time
postfootpad
inject
digit
micromet
measur
normal
measur
shamsensit
mice
altern
jhmvinfect
balbc
mice
day
pt
gfpnpc
challeng
footpad
inject
either
allogen
splenocyt
allogen
npc
footpad
swell
determin
anim
euthan
inhal
halothan
sigma
st
loui
mo
fix
cardiac
profus
spinal
cord
extract
process
oct
resin
embed
section
previous
describ
number
gfpposit
cell
count
least
two
section
apart
tissu
block
anim
count
experiment
mice
averag
data
present
averagesd
immunofluoresc
stain
ratantiplatelet
deriv
growth
factor
ebiosci
san
diego
ca
use
secondari
antibodi
use
visual
alexa
goat
antirat
invitrogen
dapi
fluoromountg
southern
biotech
birmingham
al
use
visual
nuclei
mice
infect
ip
inject
pfu
dm
viru
day
pi
cell
isol
spleen
neg
select
follow
fac
enrich
cell
subset
antigen
present
cell
apc
isol
collect
column
bound
nont
cell
enrich
apc
treat
mitomycinc
ag
scientif
apc
specif
membran
glycoprotein
span
amino
acid
residu
biosynthesi
lewisvil
tx
specif
spike
glycoprotein
span
amino
acid
residu
biosynthesi
viral
peptid
cocultur
cell
cultur
dish
gfpnpc
media
h
follow
incub
cell
cm
administ
gfpnpc
h
total
rna
extract
homogen
spinal
cord
jhmv
infect
npc
sham
transplant
balbc
mice
day
pt
cdna
gener
previous
describ
quantit
realtim
taqman
analysi
hprt
egfp
previous
describ
primer
probe
perform
use
biorad
hercul
ca
icycl
instrument
accord
manufactur
instruct
express
egfp
normal
hprt
primer
purchas
invitrogen
probe
purchas
integr
dna
technolog
coralvil
ia
biorad
iq
supermix
use
reaction
data
analyz
use
biorad
icycl
iq
version
softwar
quantifi
use
rel
express
softwar
tool
version
realtim
sybr
green
analysi
gapdh
perform
use
previous
describ
primer
biorad
sybr
green
kit
biorad
icycl
primer
forward
ttt
tcc
ttt
tgg
gca
tca
tct
revers
agc
atc
gtg
cat
tcc
tta
tca
ct
forward
tca
gca
cca
tga
acc
caa
g
revers
cta
tgg
ccc
tca
ttc
tca
ctg
forward
ctt
tgg
acc
ctc
tga
ctt
gag
revers
tca
atg
act
gtg
ccg
tgg
mrna
express
normal
gapdh
mrna
express
cell
isol
spinal
cord
experiment
mice
previous
describ
briefli
spinal
cord
remov
pbsperfus
mice
isol
tissu
ground
rubber
end
syring
plunger
petri
dish
follow
vigor
tritur
dmem
medium
singl
cell
suspens
centrifug
min
g
discontinu
percol
gradient
point
percol
lipid
layer
remov
isol
cell
filter
wash
dmem
centrifug
g
count
prepar
flow
cytometri
see
cell
isol
spleen
use
posit
control
lymphocyt
isol
spinal
cord
immunophenotyp
fluoresc
antibodi
follow
cell
surfac
marker
peconjug
bd
bioscienc
bd
bioscienc
appropri
isotyp
control
use
antibodi
cell
run
facstar
flow
cytomet
bd
bioscienc
lsrii
flow
cytomet
bd
bioscienc
analyz
flowjo
softwar
tree
star
npc
trypsin
trypsin
invitrogen
immunophenotyp
fluoresc
antibodi
specif
follow
cell
surfac
marker
peconjug
mhc
class
ebiosci
mhc
class
ii
bd
bioscienc
ebiosci
ebiosci
cell
flow
cytometri
fc
block
bd
bioscienc
min
jhmvinfect
mice
intraperiton
ip
treat
mous
either
deplet
monoclon
antibodi
american
type
cultur
collect
atcc
rockvil
md
tib
atcc
tib
control
rat
igg
sigma
steril
salin
day
pt
initi
time
point
chosen
ensur
deplet
occur
viral
clearanc
begin
prior
npc
transplant
deliveri
antibodi
everi
day
allow
effici
deplet
cell
switch
week
mainten
cell
deplet
time
point
follow
previous
publish
guidelin
variou
concentr
test
suffici
deplet
determin
flow
analysi
spleen
achiev
time
point
statist
analysi
carri
student
ttest
oneway
anova
repeat
measur
anova
consid
signific
cultur
gfpnpc
deriv
mice
b
background
treat
either
medium
alon
express
mhc
class
ii
antigen
measur
flow
cytometri
express
mhc
class
ii
antigen
increas
time
determin
stain
hour
posttreat
compar
medium
onlytr
cultur
figur
medium
onlytr
gfpnpc
express
mhc
class
ii
kinet
express
respons
treatment
differ
two
surfac
antigen
cell
figur
b
data
demonstr
cultur
npc
capabl
express
mhc
class
ii
express
mhc
class
markedli
rapid
robust
compar
mhc
class
ii
examin
express
reveal
cultur
npc
constitut
express
costimulatori
molecul
exposur
augment
express
either
molecul
figur
next
evalu
whether
allogen
npc
could
evok
cellmedi
respons
balbc
mice
background
immun
splenocyt
deriv
mice
b
background
challeng
via
footpad
inject
day
postimmun
pi
either
npc
splenocyt
deriv
either
mice
balbc
mice
within
h
postchalleng
immun
balbc
mice
expos
mhcmismatch
npc
splenocyt
display
increas
footpad
swell
splenocyt
challeng
mice
display
greater
swell
p
compar
npc
challeng
mice
p
h
swell
decreas
splenocytechalleng
mice
yet
increas
npcchalleng
anim
p
indic
although
memori
respons
follow
splenocyt
immun
stronger
splenocyt
npc
npc
capabl
induc
memori
cell
respons
figur
cell
isol
spleen
mice
day
pi
jhmv
enrich
cell
subset
cocultur
antigen
present
cell
apc
uninfect
mice
puls
viral
peptid
correspond
specif
epitop
within
membran
glycoprotein
span
amino
acid
residu
specif
epitop
within
spike
glycoprotein
span
amino
acid
residu
order
stimul
virusspecif
cell
h
media
collect
cultur
gfpnpc
treat
defin
period
time
express
mhc
class
ii
measur
flow
cytometri
similar
treatment
cm
antigen
sensit
cell
induc
mhc
class
express
cultur
gfpnpc
h
figur
b
addit
signific
increas
frequenc
mhc
class
iiposit
npc
follow
treatment
cm
viral
peptid
stimul
popul
cell
rel
treatment
figur
b
mhc
class
express
appreci
increas
gfpnpc
follow
incub
cell
condit
media
rel
mfi
analysi
determin
level
mhc
class
express
per
cell
increas
approxim
compar
treatment
although
diminish
prolong
exposur
figur
convers
mhc
class
ii
express
greater
frequenc
gfpnpc
follow
incub
cell
cm
amount
mhc
class
ii
per
cell
appreci
increas
although
mfi
mhc
class
ii
increas
later
time
point
rel
like
due
increas
number
cell
express
mhc
class
ii
shown
histogram
figur
data
demonstr
antigen
sensit
cell
capabl
induc
mhc
class
mhc
ii
express
npc
overal
increas
express
repres
presenc
addit
proinflammatori
cytokin
work
synergist
secret
virusspecif
cell
infect
suscept
mice
jhmv
induc
acut
encephalomyel
follow
immunemedi
demyelin
diseas
result
clinic
histolog
diseas
similar
human
demyelin
diseas
ms
b
background
balbc
background
mice
infect
ic
jhmv
subsequ
transplant
intraspin
inject
gfpnpc
b
background
day
pi
repres
time
demyelin
establish
recipi
mice
treat
immunomodulatori
drug
anim
sacrif
day
week
pt
surviv
engraft
cell
determin
visual
express
gfp
transplant
cell
pcr
amplif
gfp
mrna
transcript
syngen
transplant
gfpnpc
infect
mice
result
extens
migrat
along
spinal
cord
rostral
caudal
implant
site
preferenti
colon
within
area
white
matter
damag
figur
convers
allogen
gfpnpc
transplant
jhmvinfect
balbc
mice
detect
day
pt
day
pt
figur
quantif
transplant
cell
determin
count
gfpposit
cell
defin
area
rostral
caudal
implant
site
reveal
signific
differ
number
gfpnpc
present
spinal
cord
syngen
transplant
mice
compar
allogen
transplant
mice
day
pt
figur
determin
gfp
express
mrna
quantit
pcr
reveal
decreas
signal
intens
allogen
transplant
day
pt
rel
day
pt
compar
syngen
recipi
increas
gfp
transcript
level
day
pt
rel
day
pt
consist
earlier
find
engraft
cell
prolifer
figur
spinal
cord
mice
receiv
either
syngen
allogen
npc
isol
lymphocyt
infiltr
determin
day
pt
p
cell
infiltr
elev
comparison
nontranspl
jhmvinfect
mice
determin
flow
cytometr
analysi
figur
signific
increas
either
cell
follow
syngen
transplant
data
shown
next
determin
transcript
associ
cell
infiltr
elev
allogen
transplant
mice
compar
nontranspl
mice
day
pt
transcript
cell
chemoattract
figur
day
pt
chemokin
cytokin
figur
significantli
increas
p
allogen
transplant
spinal
cord
rel
sham
transplant
signific
differ
follow
syngen
transplant
data
shown
next
determin
cell
isol
transplant
mice
sensit
allogen
npc
measur
cell
prolifer
respons
npc
cocultur
us
mlr
assay
ensur
cell
prolifer
caus
potenti
contamin
apc
isol
cell
enrich
spleen
recipi
mice
subsequ
sort
fac
isol
specif
cell
popul
puriti
figur
cocultur
cell
subset
mice
day
pt
mice
show
increas
cell
prolifer
respons
exposur
either
mhcmismatch
splenocyt
well
npc
treat
medium
alon
compar
cell
nontranspl
balbc
mice
figur
notabl
treatment
significantli
alter
cell
prolif
respons
although
cell
exhibit
similar
respons
mhcmismatch
splenocyt
cell
compar
mute
respons
npc
figur
elispot
analysi
reveal
increas
p
number
cell
follow
cocultur
either
splenocyt
npc
use
stimul
compar
cell
obtain
naiv
nontranspl
mice
figur
next
test
whether
antigenrecal
respons
transplant
allogen
npc
vivo
measur
dth
respons
naiv
nontranspl
balbc
mice
gfpnpctransplant
balbc
mice
receiv
footpad
inject
gfpnpc
day
pt
major
inject
gfpnpc
transplant
mice
exhibit
increas
footpad
swell
rel
naiv
nontranspl
control
h
post
footpad
inject
increas
mice
respond
h
follow
inject
h
footpad
swell
mice
receiv
intraspin
npc
significantli
p
greater
swell
naiv
nontranspl
control
mice
figur
control
balbc
mice
receiv
subcutan
inject
gfpnpc
day
later
challeng
gfpnpc
footpad
swell
measur
day
postinject
challeng
balbc
mice
inject
allogen
gfpnpc
result
signific
p
increas
footpad
swell
day
postchalleng
compar
syngen
confirm
gfpnpc
antigen
within
context
allogen
inject
wherea
syngen
inject
elicit
immun
respons
data
shown
addit
test
confirm
import
cell
contribut
reject
mhcmismatch
npc
jhmvinfect
balbc
mice
transplant
gfpnpc
treat
deplet
monoclon
antibodi
specif
either
lymphocyt
allogen
cell
surviv
determin
week
pt
treatment
antibodi
specif
either
cell
subset
result
deplet
cell
within
peripheri
figur
top
panel
howev
within
spinal
cord
antibodi
treatment
result
reduct
cell
level
figur
bottom
panel
like
reflect
limit
penetr
monoclon
antibodi
cn
andor
mute
efficaci
deplet
cell
within
cn
nonetheless
cell
deplet
result
signific
increas
number
allogen
npc
compar
allogen
recipi
treat
control
antibodi
figur
deplet
cell
greatest
effect
allogen
npc
surviv
compar
anim
treat
cell
figur
recipi
allogen
npc
treat
surviv
npc
accumul
within
white
matter
tract
demyelin
lesion
present
wherea
treatment
restrict
migrat
cell
retain
primarili
dorsal
funiculu
figur
observ
implic
cell
import
contribut
reject
allogen
npc
final
surviv
allogen
gfpnpc
transplant
mice
treat
either
capabl
differenti
oligodendrocyt
similar
gfpnpc
syngen
transplant
without
treatment
demonstr
differenti
fate
allogen
transplant
npc
affect
antibodi
treatment
figur
use
neural
stemprogenitor
cell
treatment
human
neurolog
diseas
recogn
clinic
viabl
approach
reduc
diseas
sever
promot
recoveri
inde
human
neural
stem
cell
nsc
current
approv
use
clinic
trial
improv
function
neuron
ceroid
lipofuscinosi
fatal
neurodegen
disord
children
well
pelizaeusmerzbach
diseas
pmd
fatal
myelin
disord
wwwstemcellsinccom
addit
use
npc
shown
restor
cognit
follow
transplant
cn
mice
neuropatholog
condit
similar
observ
patient
alzheim
diseas
ad
amelior
radiationinduc
cognit
dysfunct
rat
npc
attract
use
treat
broad
array
human
neurolog
diseas
condit
base
evid
npc
capabl
differenti
distinct
glial
lineag
neuron
well
promot
neurogenesi
ongo
clinic
trial
experiment
model
neurolog
diseas
indic
evid
tumor
nonneur
tissu
format
strengthen
relev
use
cell
diseas
treatment
therefor
potenti
use
npc
restor
function
behavior
deficit
aris
loss
damag
host
cn
cell
hold
great
promis
clinic
interest
potenti
critic
aspect
better
understand
biolog
npc
transplant
relat
antigen
cell
well
abil
modul
host
immun
respons
highlight
import
area
research
conflict
report
indic
npc
immunolog
inert
welltoler
follow
transplant
mhcmismatch
anim
report
demonstr
innat
adapt
arm
immun
system
activ
particip
kill
allogen
npc
previou
studi
convincingli
demonstr
intraspin
transplant
syngen
npc
mice
persist
infect
jhmv
result
migrat
site
transplant
select
colon
area
white
matter
damag
enhanc
differenti
oligodendroglia
accompani
axon
spare
remyelin
base
upon
bodi
work
clear
transplant
cell
critic
contribut
improv
histopatholog
outcom
therefor
understand
whether
allogen
npc
surviv
follow
transplant
jhmvinfect
mice
import
regard
improv
clinic
histolog
outcom
within
context
model
also
regard
model
npc
transplant
shown
benefici
find
clearli
demonstr
mhc
mistmatch
npc
immunopriviledg
rather
antigen
follow
transplant
jhmvinfect
mice
establish
neuroinflammatorymedi
demyelin
evid
provid
support
import
role
cell
contribut
reject
npc
evok
dth
respons
follow
footpad
inject
transplant
mice
ii
cocultur
npc
cell
isol
transplant
mice
result
cell
prolifer
secret
iii
deplet
cell
subset
increas
surviv
allogen
npc
data
demonstr
treatment
cultur
npc
increas
express
mhc
class
ii
consist
earlier
studi
indic
cultur
npc
capabl
express
molecul
respons
treatment
similarli
show
cultur
npc
constitut
express
either
mhc
ii
detect
level
present
respons
treatment
exposur
cultur
npc
cm
obtain
follow
stimul
virusspecif
cell
increas
overal
frequenc
mhc
class
ii
npc
also
enhanc
express
per
cell
basi
find
reflect
npc
sensit
inflammatori
cytokin
subsequ
increas
surfac
express
mhc
antigen
lack
constitut
mhc
express
npc
consist
studi
report
embryon
stem
cell
mous
human
induc
pluripot
stem
cell
express
mhc
antigen
mute
express
mhc
antigen
stemprogenitor
cell
suggest
one
potenti
mechan
contribut
prolong
surviv
follow
transplant
mhc
incompat
host
would
limit
recognit
inflammatori
cell
also
report
costimulatori
molecul
constitut
express
npc
express
modul
follow
exposur
invitro
contrast
previou
report
show
although
mous
npc
express
costimulatori
molecul
upregul
follow
treatment
patholog
condit
collect
find
highlight
environment
inflammatori
cytokin
milieu
may
critic
regard
influenc
express
surfac
antigen
allogen
npc
allow
detect
activ
immun
cell
find
contrast
earlier
studi
indic
npc
possess
inher
immun
privileg
capabl
prolong
surviv
unsensit
host
inde
find
consist
chen
et
al
indic
allogen
npc
exhibit
limit
surviv
respons
transplant
cn
although
innat
rather
adapt
immun
respons
respons
npc
kill
model
system
howev
caution
must
exercis
consid
studi
collect
hori
et
al
chen
et
al
use
normal
recipi
mice
inflammatori
diseas
condit
present
prior
transplant
presenc
inflammatori
cytokin
within
diseas
tissu
may
relev
factor
contribut
allogen
npc
surviv
exposur
allogen
npc
proinflammatori
cytokin
upon
transplant
could
presum
increas
mhc
antigen
express
lead
recognit
infiltr
cell
consist
possibl
data
demonstr
allogen
npc
quickli
reject
follow
transplant
spinal
cord
jhmvdemyelin
spinal
cord
environ
activ
cell
secret
readili
present
moreov
demonstr
npc
sensit
exposur
condit
media
obtain
jhmvspecif
cell
stimul
defin
viral
antigen
increas
express
mhc
class
ii
antigen
base
result
cell
contribut
reject
deplet
either
subset
increas
surviv
engraft
cell
howev
greater
number
inflammatori
cell
present
within
spinal
cord
allogen
npc
recipi
compar
infiltr
cell
treatment
cell
subset
deplet
antibodi
result
enhanc
surviv
allogen
npc
compar
anim
treat
cell
subset
antibodi
data
support
recent
report
demonstr
import
role
cell
immunemedi
reject
hesc
xenograft
nevertheless
cell
clearli
sensit
allogen
npc
follow
inject
mhc
mismatch
jhmvinfect
mice
demonstr
increas
prolifer
detect
dth
respons
secret
cell
import
emphas
administr
cell
specif
deplet
antibodi
complet
elimin
cell
within
cn
although
cell
effici
deplet
peripheri
mechan
cell
particip
kill
npc
includ
direct
recognit
surfacebound
antigen
either
constitut
express
induc
upon
transplant
therefor
increas
express
mhc
antigen
transplant
allogen
npc
would
repres
potenti
target
activ
cell
present
within
spinal
cord
persistentlyinfect
mice
addit
indirect
recognit
eg
phagocyt
engulf
deaddi
npc
subsequ
present
antigen
repres
addit
scenario
cell
becom
sensit
alloantigen
unreason
scenario
mani
npc
die
inject
spinal
cord
cell
presum
remov
activ
inflammatori
macrophag
could
migrat
secondari
lymphat
tissu
present
novel
antigen
lymphocyt
altern
alloantigen
could
shed
follow
transplant
present
local
apc
follow
phagocyt
uptak
time
distinguish
whether
direct
andor
indirect
recognit
npc
antigen
occur
respons
npc
transplant
jhmvinfect
mice
howev
indirect
recognit
may
favor
import
role
cell
contribut
reject
consist
find
interestingli
also
demonstr
npc
surviv
follow
deplet
cell
subset
exhibit
normal
differenti
oligodendrocyt
progenitor
cell
opc
similar
syngen
npc
recipi
find
argu
local
microenvironment
nich
remain
capabl
provid
necessari
growth
factor
requir
fate
commit
oligodendroglia
lineag
although
cell
clearli
import
kill
allogen
npc
transplant
rule
possibl
cellular
compon
innat
immun
respons
also
contribut
reject
exampl
nk
cell
shown
involv
numer
model
allograft
reject
includ
bone
marrow
skin
cornea
allograft
observ
result
everi
allogen
npc
transplant
mous
yield
dth
swell
product
respons
allogen
npc
splenocyt
stimul
could
due
nk
cellmedi
reject
thu
limit
memori
cell
format
recent
illustr
palmer
colleagu
transplant
allogen
npc
hippocampu
normal
mice
result
dramat
reduct
surviv
result
innat
immun
respons
direct
transplant
cell
induct
immun
suppress
treatment
cyclosporin
increas
allogen
npc
surviv
yet
treatment
nonsteroid
antiinflammatori
drug
protect
npc
destruct
find
clearli
illustr
import
innat
immun
respons
particip
allograft
destruct
highlight
import
local
microenviron
allogen
npc
transplant
linger
effect
inflamm
transplant
site
like
result
kill
allograft
innat
adapt
immun
respons
conclus
find
provid
evid
allogen
npc
immun
privileg
upon
transplant
establish
inflammatori
environ
reject
rapid
involv
cell
respons
direct
npc
alloantigen
although
cell
import
mediat
immunemedi
reject
consider
use
npc
treat
chronic
neuroinflammatori
diseas
ms
use
immunomodulatori
drug
consid
order
increas
surviv
allograft
order
improv
clinic
outcom
mfi
mhc
ii
express
gfpnpc
follow
incub
cm
determin
divid
mfi
mhc
ii
follow
treatment
determin
fold
increas
mfi
flow
cytometr
analysi
perform
mononuclear
cell
isol
spinal
cord
rostral
caudal
transplant
site
use
mice
day
follow
allogen
transplant
npc
sham
transplant
two
spinal
cord
pool
cell
isol
cell
stain
peconjug
number
cell
determin
npc
transplant
sham
transplant
group
normal
mg
isol
spinal
cord
b
c
mrna
spinal
cord
mice
allogen
transplant
gfpnpc
sham
transplant
day
pt
b
day
pt
c
analyz
qrtpcr
c
valu
normal
gapdh
ratio
mrna
allogen
transplant
sham
transplant
pt
determin
allogen
transplant
compar
sham
transplant
use
calcul
statist
signific
p
standard
error
present
